Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Abbott
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patient diagnosed with moderate to severe Crohn's Disease.
Failed prior infliximab therapy.
Patient is judged to be in generally good health as determined by the principal investigator.
You may not be if
Previous treatment with adalimumab.
Patient considered by the investigator, for any reason, to be an unsuitable candidate
Clareo Health | Treatment of the Human Anti-TNF Monoclonal Antibody Adalimumab in Moderate to Severe Crohn's Disease With Previous Exposure to Infliximab (CHOICE)
